Rentschler Biopharma logo from PR.jpg
After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board
21 nov. 2022 11h30 HE | Rentschler Biopharma SE
Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016. LAUPHEIM, Germany, Nov. 21,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board
16 nov. 2022 04h00 HE | Rentschler Biopharma SE
Company increases focus on core operationsChristiane Bardroff to head global clinical and commercial manufacturing, engineering and technology operations, as well as production automation LAUPHEIM,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
18 août 2022 09h03 HE | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP
13 juin 2022 10h00 HE | Rentschler Biopharma SE
Company hires Kassim Kolia, as Vice President, Business Development to grow cell and gene therapy businessStevenage ATMP site projected to be client ready for process development in late 2022 ...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma reports strong growth and continues hiring at all three sites
20 déc. 2021 07h00 HE | Rentschler Biopharma SE
Over 300 new team members in 2021, additional new positions planned at all sitesRentschler Biopharma again named one of “most attractive employers” in Germany by the F.A.Z. Institute and awarded first...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Inc. Recognized by Massachusetts House of Representatives as Manufacturer of the Year for District
29 sept. 2021 09h19 HE | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
22 sept. 2021 07h00 HE | Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus
20 sept. 2021 07h00 HE | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
12 août 2021 08h00 HE | Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
31 mars 2021 04h00 HE | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...